BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 195 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,893 | +0.6% | 37,273 | -0.0% | 0.00% | 0.0% |
| Q2 2023 | $262,416 | +11.1% | 37,275 | +31.6% | 0.00% | 0.0% |
| Q1 2023 | $236,272 | -22.8% | 28,330 | +6.2% | 0.00% | -50.0% |
| Q4 2022 | $306,137 | -4.0% | 26,667 | +5.3% | 0.00% | 0.0% |
| Q3 2022 | $319,000 | +19.0% | 25,322 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $268,000 | -35.0% | 25,322 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $412,000 | -2.6% | 25,322 | -17.1% | 0.00% | 0.0% |
| Q4 2021 | $423,000 | +9.6% | 30,547 | +13.8% | 0.00% | 0.0% |
| Q3 2021 | $386,000 | -8.7% | 26,832 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $423,000 | +70.6% | 26,766 | +9.9% | 0.00% | +100.0% |
| Q1 2021 | $248,000 | +40.1% | 24,353 | +2.4% | 0.00% | 0.0% |
| Q4 2020 | $177,000 | +115.9% | 23,789 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $82,000 | -27.4% | 23,789 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $113,000 | +222.9% | 23,789 | +35.5% | 0.00% | – |
| Q1 2020 | $35,000 | +66.7% | 17,560 | +184.7% | 0.00% | – |
| Q4 2019 | $21,000 | +16.7% | 6,168 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | -21.7% | 6,168 | 0.0% | 0.00% | – |
| Q2 2019 | $23,000 | -54.0% | 6,168 | 0.0% | 0.00% | – |
| Q1 2019 | $50,000 | 0.0% | 6,168 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $50,000 | +6.4% | 6,168 | 0.0% | 0.00% | – |
| Q3 2018 | $47,000 | +34.3% | 6,168 | 0.0% | 0.00% | – |
| Q2 2018 | $35,000 | +20.7% | 6,168 | 0.0% | 0.00% | – |
| Q1 2018 | $29,000 | -3.3% | 6,168 | 0.0% | 0.00% | – |
| Q4 2017 | $30,000 | +233.3% | 6,168 | +242.5% | 0.00% | – |
| Q3 2017 | $9,000 | -10.0% | 1,801 | 0.0% | 0.00% | – |
| Q2 2017 | $10,000 | -33.3% | 1,801 | 0.0% | 0.00% | – |
| Q1 2017 | $15,000 | +36.4% | 1,801 | 0.0% | 0.00% | – |
| Q4 2016 | $11,000 | +37.5% | 1,801 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | +60.0% | 1,801 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | 0.0% | 1,801 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -73.7% | 1,801 | 0.0% | 0.00% | – |
| Q4 2015 | $19,000 | +137.5% | 1,801 | +166.8% | 0.00% | – |
| Q3 2015 | $8,000 | – | 675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |